Dr. Jonathan Loree, Dr
Claim this profileBC Cancer Agency
Studies Neuroendocrine Tumors
1 reported clinical trial
3 drugs studied
Area of expertise
1Neuroendocrine Tumors
Stage IV
Stage III
More about Jonathan Loree, Dr
Clinical Trial Related4 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Jonathan Loree, Dr has experience with
- High Dose Long-acting Octreotide
- Long-acting Octreotide
- Lutathera
Breakdown of trials Jonathan Loree, Dr has run
Neuroendocrine Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jonathan Loree, Dr specialize in?
Jonathan Loree, Dr focuses on Neuroendocrine Tumors and other conditions. In particular, much of their work with Neuroendocrine Tumors has involved Stage IV patients, or patients who are Stage III.
Is Jonathan Loree, Dr currently recruiting for clinical trials?
No, Jonathan Loree, Dr is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Jonathan Loree, Dr has studied deeply?
Yes, Jonathan Loree, Dr has studied treatments such as high dose long-acting octreotide, long-acting octreotide, Lutathera.
What is the best way to schedule an appointment with Jonathan Loree, Dr?
Apply for one of the trials that Jonathan Loree, Dr is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.